Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2008

Open Access 01-01-2008 | Review

MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature

Authors: Ritse M. Mann, Yvonne L. Hoogeveen, Johan G. Blickman, Carla Boetes

Published in: Breast Cancer Research and Treatment | Issue 1/2008

Login to get access

Abstract

Purpose

The clinical diagnosis and management of invasive lobular carcinoma (ILC) of the breast presents difficulties. Magnetic resonance imaging (MRI) has been proposed as the imaging modality of choice for the evaluation of ILC. Small studies addressing different aspects of MRI in ILC have been presented but no large series to date. To address the usefulness of MRI in the work-up of ILC, we performed a review of the currently published literature.

Materials and methods

We performed a literature search using the query “lobular AND (MRI OR MR OR MRT OR magnetic)” in the Cochrane library, PubMed and scholar.google.com, to retrieve all articles that dealt with the use of MRI in patients with ILC. We addressed sensitivity, morphologic appearance, correlation with pathology, detection of additional lesions, and impact of MRI on surgery as different endpoints. Whenever possible we performed meta-analysis of the pooled data.

Results

Sensitivity is 93.3% and equal to overall sensitivity of MRI for malignancy in the breast. Morphologic appearance is highly heterogeneous and probably heavily influenced by interreader variability. Correlation with pathology ranges from 0.81 to 0.97; overestimation of lesion size occurs but is rare. In 32% of patients, additional ipsilateral lesions are detected and in 7% contralateral lesions are only detected by MRI. Consequently, MRI induces change in surgical management in 28.3% of cases.

Conclusion

This analysis indicates MRI to be valuable in the work-up of ILC. It provides additional knowledge that cannot be obtained by conventional imaging modalities which can be helpful in patient treatment.
Literature
1.
Arpino G, Bardou VJ, Clark GM, Elledge RM (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6(3):R149–R156PubMedCrossRef
2.
Hussien M, Lioe TF, Finnegan J, Spence RA (2003) Surgical treatment for invasive lobular carcinoma of the breast. Breast 12(1):23–35PubMedCrossRef
3.
Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421–1424PubMedCrossRef
4.
Peiro G, Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, Nixon AJ, Recht A, Silver B, Harris JR, Schnitt SJ (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59(1):49–54PubMedCrossRef
5.
Yeatman TJ, Cantor AB, Smith TJ, Smith SK, Reintgen DS, Miller MS, Ku NN, Baekey PA, Cox CE (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222(4):549–559PubMedCrossRef
6.
Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R (2006) Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 15(5):946–954PubMedCrossRef
7.
Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9):1046–1052PubMedCrossRef
8.
Schnitt SJ, Guidi AJ (2004) Pathology of invasive breast cancer. In: Harris JR, Morrow M, Osborne CK, Lippman ME (eds) Diseases of the breast, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia
9.
Qureshi HS, Linden MD, Divine G, Raju UB (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125(3):377–385PubMedCrossRef
10.
Le Gal M, Ollivier L, Asselain B, Meunier M, Laurent M, Vielh P, Neuenschwander S (1992) Mammographic features of 455 invasive lobular carcinomas. Radiology 185(3):705–708PubMed
11.
Dillon MF, Hill AD, Fleming FJ, O’Doherty A, Quinn CM, McDermott EW, O’Higgins N (2006) Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma. Am J Surg 191(2):201–205PubMedCrossRef
12.
Paumier A, Sagan C, Campion L, Fiche M, Andrieux N, Dravet F, Pioud R, Classe JM (2003) Évaluation de la validité du traitement conservateur dans le carcinome lobulaire infiltrant du sein: À propos d’une étude rétrospective portant sur 217 carcinomes lobulaires infiltrants et 2155 carcinomes canalaires infiltrants. J Gynecol Obstet Biol Reprod (Paris) 32(6):529–534
13.
Orel SG, Schnall MD (2001) MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220(1):13–30PubMed
14.
Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, Barclay J, Schnall MD (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13(6):889–895PubMedCrossRef
15.
Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6:9PubMedCrossRef
16.
Corey DM, Dunlap WP, Burke MJ (1998) Averaging correlations: expected values and bias in combined Pearson rs and Fisher’s z transformations. J Gen Psychol 125(3):245–261CrossRef
17.
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560PubMedCrossRef
18.
Bazzocchi M, Facecchia I, Zuiani C, Puglisi F, Di LC, Smania S (2000) Diagnostic imaging of lobular carcinoma of the breast: mammographic, ultrasonographic and MR findings. Radiol Med (Torino) 100(6):436–443
19.
Boetes C, Veltman J, Van DL, Bult P, Wobbes T, Barentsz JO (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86(1):31–37PubMedCrossRef
20.
Cooney BS, Orel SG, Schnall MD, Troupin RH (1994) Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: detection with MR imaging. AJR Am J Roentgenol 162(6):1318–1320PubMed
21.
Dalpiaz G, Zingarelli A, Anania G, Bazzocchi M (1996) Apporto della risonanza magnetica in un caso di adenocarcinoma lobulare della mammella. Radiol Med (Torino) 91(4):475–477
22.
Diekmann F, Diekmann S, Beljavskaja M, Bick U, Taupitz M, Blohmer JU, Winzer KJ, Hamm B (2004) Präoperative MRT der Brust beim invasiv-lobulären im Vergleich zum invasiv-duktalen Karzinom. Rofo 176(4):544–549PubMed
23.
Fabre Demard N, Boulet P, Prat X, Charra L, Lesnik A, Taourel P (2005) Apport de l’IRM dans le diagnostic et le bilan d’extension des cancers lobulaires infiltrants. J Radiol 86(9 Pt 1):1027–1034PubMed
24.
Francis A, England DW, Rowlands DC, Wadley M, Walker C, Bradley SA (2001) The diagnosis of invasive lobular breast carcinoma. Does MRI have a role? Breast 10(1):38–40
25.
Kepple J, Layeeque R, Klimberg VS, Harms S, Siegel E, Korourian S, Gusmano F, Henry-Tillman RS (2005) Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190(4):623–627PubMedCrossRef
26.
Kneeshaw PJ, Turnbull LW, Smith A, Drew PJ (2003) Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol 29(1):32–37PubMedCrossRef
27.
Leung J, Kinkel K, Wang WL, Sickles EA, Hylton NM (2000) Morphologic and kinetic characteristics of lobular carcinoma of the breast at MR imaging. AJR Am J Roentgenol 174(Supplement):48
28.
Munot K, Dall B, Achuthan R, Parkin G, Lane S, Horgan K (2002) Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg 89(10):1296–1301PubMedCrossRef
29.
Nokes SR, Pierce WB, Abraham DC, Harms SE (1999) Radiology. Infiltrating lobular carcinoma. J Ark Med Soc 96(5):176–177PubMed
30.
Qayyum A, Birdwell RL, Daniel BL, Nowels KW, Jeffrey SS, Agoston TA, Herfkens RJ (2002) MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 178(5):1227–1232PubMed
31.
Quan ML, Sclafani L, Heerdt AS, Fey JV, Morris EA, Borgen PI (2003) Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol 10(9):1048–1053PubMedCrossRef
32.
Rodenko GN, Harms SE, Pruneda JM, Farrell RS Jr, Evans WP, Copit DS, Krakos PA, Flamig DP (1996) MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol 167(6):1415–1419PubMed
33.
Schelfout K, Van GM, Kersschot E, Verslegers I, Biltjes I, Leyman P, Colpaert C, Thienpont L, Van Den HJ, Gillardin JP, Tjalma W, Buytaert P, De SA (2004) Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol 14(7):1209–1216PubMedCrossRef
34.
Sittek H, Perlet C, Untch M, Kessler M, Reiser M (1998) Dynamische MR-Mammographie beim invasive lobulären Mammakarzinom bei 1,0T. Rontgenpraxis 51(7):235–242PubMed
35.
Trecate G, Tess JD, Vergnaghi D, Bergonzi S, Mariani G, Ferraris C, Musumeci R (2001) Lobular breast cancer: how useful is breast magnetic resonance imaging? Tumori 87(4):232–238PubMed
36.
Weinstein SP, Orel SG, Heller R, Reynolds C, Czerniecki B, Solin LJ, Schnall M (2001) MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 176(2):399–406PubMed
37.
Wilhelm K, Grebe P, Teifke A, Halbsguth A, Mitze M, Thelen M (1992) Das lobuläre Mammakarzinom in der Kernspintomographie. Aktuelle Radiol 2(6):373–375PubMed
38.
Yeh ED, Slanetz PJ, Edmister WB, Talele A, Monticciolo D, Kopans DB (2003) Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J 9(1):13–18PubMedCrossRef
39.
Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF, Fraker DL, Czerniecki BJ (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98(3):468–473PubMedCrossRef
40.
Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, Ioffe OB (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233(3):830–849PubMedCrossRef
41.
Kim SJ, Morris EA, Liberman L, Ballon DJ, La Trenta LR, Hadar O, Abramson A, Dershaw DD (2001) Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses. AJR Am J Roentgenol 177(3):551–557PubMed
42.
Newstead G, Arkani S, Abe H, Schmidt R, Senett C, Yang C (2005) Dynamic breast MR imaging: comparison of kinetic and morphologic characteristics of malignant lesions by tumor type and grade. RSNA SSM01–05
43.
Kneeshaw PJ, Turnbull LW, Drew PJ (2003) Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg 90(2):248PubMedCrossRef
44.
Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10(3):223–232PubMedCrossRef
45.
Helvie MA, Paramagul C, Oberman HA, Adler DD (1993) Invasive lobular carcinoma. Imaging features and clinical detection. Invest Radiol 28(3):202–207PubMedCrossRef
46.
Hilleren DJ, Andersson IT, Lindholm K, Linnell FS (1991) Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology 178(1):149–154PubMed
47.
Paramagul CP, Helvie MA, Adler DD (1995) Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology 195(1):231–234PubMed
48.
Cornford EJ, Wilson AR, Athanassiou E, Galea M, Ellis IO, Elston CW, Blamey RW (1995) Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol 68(809):450–453PubMedCrossRef
49.
Krecke KN, Gisvold JJ (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 161(5):957–960PubMed
50.
Newstead GM, Baute PB, Toth HK (1992) Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 184(3):623–627PubMed
51.
Uchiyama N, Miyakawa K, Moriyama N, Kumazaki T (2001) Radiographic features of invasive lobular carcinoma of the breast. Radiat Med 19(1):19–25PubMed
52.
Veltman J, Boetes C, van Die L, Bult P, Blickman JG, Barentsz JO (2006) Mammographic detection and staging of invasive lobular carcinoma. Clin Imaging 30(2):94–98PubMedCrossRef
53.
Cawson JN, Law EM, Kavanagh AM (2001) Invasive lobular carcinoma: sonographic features of cancers detected in a BreastScreen Program. Australas Radiol 45(1):25–30PubMedCrossRef
54.
Chapellier C, Balu-Maestro C, Bleuse A, Ettore F, Bruneton JN (2000) Ultrasonography of invasive lobular carcinoma of the breast: sonographic patterns and diagnostic value: report of 102 cases. Clin Imaging 24(6):333–336PubMedCrossRef
55.
Evans N, Lyons K (2000) The use of ultrasound in the diagnosis of invasive lobular carcinoma of the breast less than 10 mm in size. Clin Radiol 55(4):261–263PubMedCrossRef
56.
Rissanen T, Tikkakoski T, Autio AL, Apaja-Sarkkinen M (1998) Ultrasonography of invasive lobular breast carcinoma. Acta Radiol 39(3):285–291PubMedCrossRef
57.
Selinko VL, Middleton LP, Dempsey PJ (2004) Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound 32(7):323–332PubMedCrossRef
58.
Skaane P, Skjorten F (1999) Ultrasonographic evaluation of invasive lobular carcinoma. Acta Radiol 40(4):369–375PubMed
59.
Pointon KS, Cunningham DA (1999) Ultrasound findings in pure invasive lobular carcinoma of the breast: comparison with matched cases of invasive ductal carcinoma of the breast. Breast 8(4):188–190PubMedCrossRef
60.
Drew PJ, Chatterjee S, Turnbull LW, Read J, Carleton PJ, Fox JN, Monson JR, Kerin MJ (1999) Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol 6(6):599–603PubMedCrossRef
61.
Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213(3):881–888PubMed
62.
Heywang-Kobrunner SH, Bick U, Bradley WG Jr, Bone B, Casselman J, Coulthard A, Fischer U, Muller-Schimpfle M, Oellinger H, Patt R, Teubner J, Friedrich M, Newstead G, Holland R, Schauer A, Sickles EA, Tabar L, Waisman J, Wernecke KD (2001) International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11(4):531–546PubMedCrossRef
63.
Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R (1997) MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21(5):773–779PubMedCrossRef
64.
Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S, Heywang-Kobrunner SH, Hylton N, Kuhl CK, Lehman C, Pisano ED, Causer P, Schnitt SJ, Smazal SF, Stelling CB, Weatherall PT, Schnall MD (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292(22):2735–2742PubMedCrossRef
65.
Stoutjesdijk MJ, Futterer JJ, Boetes C, van Die LE, Jager G, Barentsz JO (2005) Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging. Invest Radiol 40(6):355–362PubMedCrossRef
66.
Boetes C, Strijk SP, Holland R, Barentsz JO, Van Der Sluis RF, Ruijs JH (1997) False-negative MR imaging of malignant breast tumors. Eur Radiol 7(8):1231–1234PubMedCrossRef
67.
Korhonen T, Huhtala H, Holli K (2004) A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat 85(1):23–29PubMedCrossRef
68.
Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ (2004) Infiltrating lobular carcinoma—a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast 13(5):389–396PubMedCrossRef
69.
Lee AH, Dublin EA, Bobrow LG, Poulsom R (1998) Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol 185(4):394–401PubMedCrossRef
70.
Tresserra F, Feu J, Grases PJ, Navarro B, Alegret X, Fernandez-Cid A (1999) Assessment of breast cancer size: sonographic and pathologic correlation. J Clin Ultrasound 27(9):485–491PubMedCrossRef
71.
Watermann DO, Tempfer C, Hefler LA, Parat C, Stickeler E (2005) Ultrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer. Ultrasound Med Biol 31(2):167–174PubMedCrossRef
72.
Mersin H, Yildirim E, Gulben K, Berberoglu U (2003) Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 29(4):390–395PubMedCrossRef
73.
Kurtz JM, Jacquemier J, Torhorst J, Spitalier JM, Amalric R, Hunig R, Walther E, Harder F, Almendral A, Brandone H (1989) Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63(8):1630–1635PubMedCrossRef
74.
Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77(1):113–120PubMedCrossRef
75.
Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR (1989) Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64(2):448–454PubMedCrossRef
76.
Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA (2006) Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 106(12):2563–2568PubMedCrossRef
77.
Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK (2006) Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 192(4):552–555PubMedCrossRef
78.
Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ (2005) Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience. Cancer 103(12):2447–2454PubMedCrossRef
Metadata
Title
MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature
Authors
Ritse M. Mann
Yvonne L. Hoogeveen
Johan G. Blickman
Carla Boetes
Publication date
01-01-2008
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2008
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9528-5

Other articles of this Issue 1/2008

Breast Cancer Research and Treatment 1/2008 Go to the issue

Preclinical Study

Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation

Clinical Trial

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen

Preclinical Study/Clinical Trial/Epidemiology/Invited Commentary

Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

Preclinical Study

Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of α-difluoromethylornithine in breast cancer cells

Preclinical Study/Clinical Trial/Epidmiology/Invited Commentary

Screening for ATM sequence alterations in African-American women diagnosed with breast cancer

Preclinical Study

Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits